Get the Stockscreener App
0.375
5.21%
-0.0206
After Hours:
.37
-0.005
-1.33%
Xtant Medical Holdings Inc stock is traded at $0.375, with a volume of 379.06K.
It is down -5.21% in the last 24 hours and down -13.95% over the past month.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.3956
Open:
$0.3941
24h Volume:
379.06K
Relative Volume:
0.24
Market Cap:
$52.61M
Revenue:
$121.91M
Net Income/Loss:
$1.83M
P/E Ratio:
34.40
EPS:
0.0109
Net Cash Flow:
$7.75M
1W Performance:
-2.34%
1M Performance:
-13.95%
6M Performance:
-40.85%
1Y Performance:
-38.53%
1-Day Range:
$0.3701
$0.4035
1-Week Range:
$0.346
$0.4364
52-Week Range:
$0.2702
$0.95
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.375 | 46.76M | 121.91M | 1.83M | 7.75M | 0.0109 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-23 | Initiated | BTIG Research | Buy |
| Nov-15-18 | Reiterated | Maxim Group | Buy |
| Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference - Eastern Progress
XTNT stock focus shifts to latest medical device results and valuation - AD HOC NEWS
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com South Africa
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Xtant Medical Shares Surge 16% Following BioHorizons Deal to Distribute Prolifica in Dental Market - TechStock²
XTNT SEC FilingsXtant Medical Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Xtant Medical partners with BioHorizons for dental distribution By Investing.com - Investing.com Nigeria
BioHorizons will exclusively sell Xtant’s growth factor in the U.S. and Canada - Stock Titan
Xtant Medical partners with BioHorizons for dental distribution - Investing.com
Xtant Medical Earnings Call: Growth Bets Amid Setbacks - TipRanks
ETFs Investing in Xtant Medical Holdings, Inc. Stocks - TradingView
Xtant (XTNT) Financial Results: Profit Per Share Falls Below Its Benchmark in the Latest Session; Price Move - vinanet.vn
Xtant Medical (XTNT) insider reports new stock transaction - Stock Titan
Xtant Medical (XTNT) insider updates SEC on stock transaction - Stock Titan
Xtant Medical (XTNT) grants COO 450K DSUs vesting 2027–30 - Stock Titan
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Maze Therapeutics, Inc. (MAZE) and Xtant Medical Holdings (XTNT) - theglobeandmail.com
Xtant Medical Q2 2026 Earnings Call Transcript - MarketBeat
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ... - Yahoo Finance
XTNT: Expanded sales force, new products, and asset sales drive growth and cash generation outlook - TradingView
Xtant Medical Holdings Releases Q2 2026 Financial Results - AlphaStreet
Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Xtant Medical Cuts 2026 Revenue Guidance After Weak Biologics Sales and Amnio Headwinds - Minichart
Xtant Medical Holdings, Inc. (XTNT) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com South Africa
XTNT: Revenue and margins fell sharply, with a net loss and heightened supply chain risks - TradingView
Xtant Medical (XTNT) revenue drops 35% and turns to loss on divestitures, Dilon charge - Stock Titan
Xtant Medical Q2 2026 Earnings: Revenue Declines as Margins Contract - TradingKey
Xtant Medical Q2 Revenue Falls To $23.0 Million - Quiver Quantitative
XTNT: Q2 2026 saw revenue drop, margin compression, and a net loss, prompting lower full-year guidance - tradingview.com
Xtant Medical Holdings, Inc. Lowers Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Xtant Medical Holdings (XTNT) Plunges 28% to $0.32 as Selling Pressure MountsDouble EMA - dars.gov.et
XTNT Q1 2026 Earnings: EPS Misses Estimates, Shares Slip 0.09Earnings Acceleration Picks - vinanet.vn
Xtant Medical Stockholders Approve Governance and Leadership Items - TipRanks
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026 - Morningstar
Xtant Medical (XTNT) Posts Modest Gain, Holds Support at $0.42 Amid Rangebound TradingEqual Weight ETF - dars.gov.et
XTNT Q1 2026 Earnings: Wider-Than-Expected Loss Triggers Modest Share DeclineEarnings Per Share - vinanet.vn
Xtant Medical (XTNT) Expected to Release Quarterly Earnings on Monday - MarketBeat
Xtant Medical Holdings, Inc. Revenue Breakdown – AMEX:XTNT - TradingView
Xtant Medical Holdings Inc (XTNT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.003 - TradingKey
TradingKey - TradingKey
Xtant Medical Holdings Inc (XTNT) Cash Flow - TradingKey
Xtant Medical Holdings Inc (XTNT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.001 - TradingKey
Xtant Medical Holdings Inc (XTNT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xtant Medical (XTNT) Consolidates Near $0.43 with Minimal MovementWave Extension - vinanet.vn
Xtant Medical Holdings (XTNT) Edges Higher as Key Levels TestedAAII Neutral - vinanet.vn
XTNT Q1 2026 Earnings: EPS Misses Estimates Despite Modest Stock GainProfitability Analysis - vinanet.vn
XTNT stock trades around recent lows as Xtant Medical revenue climbs and losses narrow - Ad-hoc-news.de
SemiLEDs And 2 Other Promising Penny Stocks To Watch - simplywall.st
XTNT Q1 2026 Earnings: Wider Loss Than Expected Sends Shares LowerTangible Book Value - vinanet.vn
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):